News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
149 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18719)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
BioMidwest
Invacare Declares Quarterly Dividend - Nov. 16, 2017
The company declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable January 16, 2018.
November 16, 2017
·
1 min read
VM BioPharma Announces Generic Name “donaperminogene seltoplasmid” for Investigational Novel Gene Therapy, VM202
The movement of donaperminogene seltoplasmid toward commercialization is further evidenced by the ongoing enrollment of two Phase III studies within the US.
November 16, 2017
·
3 min read
Biotech Bay
Personalis Launches Early Access Program for Cell-Free DNA ACE Exome for Tumor Neoantigens
The company also stated that the program will be offered exclusively to its immuno-oncology partners.
November 16, 2017
·
2 min read
Business
CSSB and Leica Microsystems Establish an Advanced Light and Fluorescence Microscopy (ALFM) Facility and Integrated Cryo-Imaging Solutions
The partnership, being announced to coincide with the Opening Symposium of the CSSB, will see major collaboration between the two parties for the development of new integrated Cryo-Imaging solutions and the establishment of an advanced microscopy facility.
November 16, 2017
·
2 min read
Genetown
Mauna Kea Technologies Announces Reimbursement Coverage for Cellvizio in Croatia
The Croatian Health Insurance Fund provides healthcare coverage for the country’s estimated 4.2 million citizens.
November 16, 2017
·
3 min read
Policy
MMS Selected by Paratek to Support its NDA Submissions for Omadacycline
MMS announced today that it was selected by Paratek Pharma to support the development of its U.S. NDAs for omadacycline.
November 16, 2017
·
3 min read
Biotech Bay
PacBio and GENEWIZ Announce Winner of the 2017 AACR SMRT Grant
With this SMRT Grant, Dr. Ludlow will receive Iso-Seq analysis on the PacBio Sequel System at the GENEWIZ laboratory to further his investigation to understand the splicing of transcripts regulated by NOVA1 in lung cancer cells.
November 16, 2017
·
3 min read
Drug Development
Vium Announces First Peer-Reviewed Publication for its Digital Vivarium Technology
The peer reviewed paper was published in the journal Frontiers in Pharmacology.
November 16, 2017
·
2 min read
MindBytes BVBA Initiates Oncology R&D Program Focused on Patient Empowerment and is Selected as One of Five Finalists for Astellas Oncology C3 Prize
MindBytes believes these tools can empower patients and play an important role in addressing ongoing challenges in cancer care.
November 16, 2017
·
4 min read
FDA
FDA Gives Clearance for Innovative Health Solution’s Breakthrough Opioid Addiction Withdrawal Treatment
The NSS-2 BRIDGE device is pioneered and developed by an Indiana medical technology company.
November 16, 2017
·
2 min read
Previous
7 of 15
Next